GRAY SUSANNAH
SEC insider (Form 3/4/5 filer). CIK 0001833453. Director at Theravance Biopharma, Inc. (TBPH) and 3 other issuers. 9 reported Form 4/5 transactions since Sep 2024; latest on Sep 23, 2026. Located in SOUTH SAN FRANCISCO, CA.
Companies GRAY SUSANNAH has filed insider reports for
- Theravance Biopharma, Inc. (TBPH): Director
- 4D Molecular Therapeutics, Inc. (FDMT): Director
- MARAVAI LIFESCIENCES HOLDINGS, INC. (MRVI): Director
- ANAPTYSBIO, INC (ANAB): Director
GRAY SUSANNAH
CIK: 0001833453
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (9 total)
- Sep 23, 2026TBPH
Theravance Biopharma, Inc.
DispositionDirect42.1K shares- - Sep 23, 2026TBPH
Theravance Biopharma, Inc.
DispositionDirect6K shares- - Jun 17, 2026FDMT
4D Molecular Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
50K shares- - Jun 12, 2026TBPH
Theravance Biopharma, Inc.
AwardDirect6K shares- - May 26, 2026MRVI
MARAVAI LIFESCIENCES HOLDINGS, INC.
AwardDirect46.3K shares- - Apr 27, 2026ANAB
ANAPTYSBIO, INC
AwardDirectRestricted Stock Unit
11.3K shares- - Jun 17, 2025FDMT
4D Molecular Therapeutics, Inc.
AwardDirectStock Option (Right to Buy)
22.5K shares- - Jun 16, 2025MRVI
MARAVAI LIFESCIENCES HOLDINGS, INC.
AwardDirect89.1K shares at avg. $2.16$193K - May 19, 2025TBPH
Theravance Biopharma, Inc.
AwardDirect10.6K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 23, 2026 |  TBPH Theravance Biopharma, Inc. | Disposition | 42,137 | - | $0 | Direct |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Disposition | 6,009 | - | $0 | Direct |
| Jun 17, 2026 |  FDMT 4D Molecular Therapeutics, Inc. | Award Stock Option (Right to Buy) | 50,000 | - | - | Direct |
| Jun 12, 2026 | TBPH Theravance Biopharma, Inc. | Award | 6,009 | - | $0 | Direct |
| May 26, 2026 |  MRVI MARAVAI LIFESCIENCES HOLDINGS, INC. | Award | 46,293 | - | $0 | Direct |
| Apr 27, 2026 |  ANAB ANAPTYSBIO, INC | Award Restricted Stock Unit | 11,250 | - | - | Direct |
| Jun 17, 2025 | FDMT 4D Molecular Therapeutics, Inc. | Award Stock Option (Right to Buy) | 22,500 | - | - | Direct |
| Jun 16, 2025 | MRVI MARAVAI LIFESCIENCES HOLDINGS, INC. | Award | 89,139 | $2.16 | $192,540 | Direct |
| May 19, 2025 | TBPH Theravance Biopharma, Inc. | Award | 10,649 | - | - | Direct |
1-9 of 9 transactions